A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
Bioceres Crop Solutions Corp.
BIOX
$9M
Mkt Cap
$0.42
-0.82%
Business description not available.
| Metric | TTM | FY2021 |
|---|---|---|
| Revenue | 210M | 210M |
| Net Income | -3.8M | -3.8M |
| EPS | $-0.18 | $-0.18 |
| Free Cash Flow | -9.0M | -9.0M |
| ROIC | -7.5% | 15.2% |
| Gross Margin | 43.4% | 43.4% |
| Debt/Equity | 1.38 | 1.38 |
| Dividends/Share | $0.00 | - |
| Operating Income | 38M | 38M |
| Operating Margin | 18.3% | 18.3% |
| ROE | -4.2% | -5.1% |
| Shares Outstanding | 22M | 22M |
| Metric | 2021 | TTM |
|---|---|---|
| Income Statement | ||
| Revenue | 210M | 210M |
| Gross Margin | 43.4% | 43.4% |
| R&D | 5.6M | 5.6M |
| SG&A | 48M | 48M |
| EBIT | 38M | 38M |
| Op. Margin | 18.3% | 18.3% |
| Net Income | -3.8M | -3.8M |
| Net Margin | -1.8% | -1.8% |
| Non-Recurring | 0 | 0 |
| Returns on Capital | ||
| ROIC | 15.2% | -7.5% |
| ROE | -5.1% | -4.2% |
| ROA | -1.1% | -1.0% |
| Cash Flow | ||
| Op. Cash Flow | -6.2M | -6.2M |
| Free Cash Flow | -9.0M | -9.0M |
| Owner Earnings | -9.3M | -9.3M |
| CapEx | 2.8M | 2.8M |
| Maint. CapEx | 3.0M | 3.0M |
| Growth CapEx | 0 | 0 |
| D&A | 3.0M | 3.0M |
| CapEx/OCF | N/A | 0.0% |
| Capital Allocation | ||
| Dividends Paid | 0 | 0 |
| Dividend Yield | N/A | N/A |
| Share Buybacks | 0 | 0 |
| Buyback Yield | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A |
| Debt Repayment | 113M | 113M |
| Balance Sheet | ||
| Net Debt | 89M | 96M |
| Cash & Equiv. | 28M | 28M |
| Long-Term Debt | 48M | 48M |
| Debt/Equity | 1.38 | 1.38 |
| Interest Coverage | 2.2 | 2.2 |
| Equity | 90M | 90M |
| Total Assets | 395M | 395M |
| Total Liabilities | 304M | 304M |
| Intangibles | N/A | N/A |
| Retained Earnings | N/A | N/A |
| Working Capital | 43M | 43M |
| Current Assets | 211M | 211M |
| Current Liabilities | 168M | 168M |
| Per Share Data | ||
| EPS | -0.18 | -0.18 |
| Owner EPS | -0.42 | -0.42 |
| Book Value | 4.14 | 4.14 |
| Cash Flow/Share | -0.28 | -0.04 |
| Dividends/Share | N/A | 0.00 |
| Shares Out. | 21.8M | 21.8M |
| Valuation | ||
| P/E Ratio | N/A | -2.4 |
| P/FCF | N/A | N/A |
| EV/EBIT | N/A | 2.8 |
| Price/Book | N/A | 0.1 |
| Price/Sales | N/A | 0.0 |
| FCF Yield | N/A | -97.8% |
| Market Cap | 0 | 9.2M |
| Avg. Price | 0.00 | 0.42 |
| Year-End Price | 0.00 | 0.42 |
Bioceres Crop Solutions Corp. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average ROIC is 15.2% with a gross margin of 43.4%.
Bioceres Crop Solutions Corp. (BIOX) has a 5-year average return on invested capital (ROIC) of 15.2%. This indicates strong capital allocation and a potential competitive advantage.
Bioceres Crop Solutions Corp. (BIOX) has a market capitalization of $9M. It is classified as a small-cap stock.
Bioceres Crop Solutions Corp. (BIOX) does not currently pay a regular dividend.
Bioceres Crop Solutions Corp. (BIOX) reported annual revenue of $210 million in its most recent fiscal year, based on SEC EDGAR filings.
Bioceres Crop Solutions Corp. (BIOX) has a net profit margin of -1.8%. The company is currently unprofitable.
Bioceres Crop Solutions Corp. (BIOX) generated $-9 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Bioceres Crop Solutions Corp. (BIOX) has a debt-to-equity ratio of 1.38. This indicates moderate leverage.
Bioceres Crop Solutions Corp. (BIOX) reported earnings per share (EPS) of $-0.18 in its most recent fiscal year.
Bioceres Crop Solutions Corp. (BIOX) has a return on equity (ROE) of -5.1%. A negative ROE may indicate losses or negative equity.
Bioceres Crop Solutions Corp. (BIOX) has a 5-year average gross margin of 43.4%. This indicates decent pricing power.
The Ledger Terminal provides 1 years of financial data for Bioceres Crop Solutions Corp. (BIOX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Bioceres Crop Solutions Corp. (BIOX) has a book value per share of $4.14, based on its most recent annual SEC filing.